November 3, 2022 11:06 AM EDTUpdated November 4, 02:10 PM
Manufacturing

Man­u­fac­tur­ing roundup: Teru­mo Phar­ma­ceu­ti­cal So­lu­tions ex­pand­ing CD­MO reach out­side Japan; EU­ROAPI boost­ing pro­duc­tion at Frank­furt site

Tyler Patchen

News Reporter

The CD­MO arm of the Teru­mo Cor­po­ra­tion is look­ing to branch out of Japan and of­fer its ser­vices in oth­er na­tions.

Teru­mo Phar­ma­ceu­ti­cal So­lu­tions will …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

2024's bio­phar­ma win­ners and losers; Ca­griSe­ma falls short; Mer­ck swings Chi­na GLP-1 deal; and more

A service from the Financial Times